Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Sep;92(3):1548–1554. doi: 10.1172/JCI116734

Differentiation and long-term survival of C2C12 myoblast grafts in heart.

G Y Koh 1, M G Klug 1, M H Soonpaa 1, L J Field 1
PMCID: PMC288302  PMID: 8376605

Abstract

We have assessed the ability of skeletal myoblasts to form long-term, differentiated grafts in ventricular myocardium. C2C12 myoblasts were grafted directly into the heart of syngeneic mice. Viable grafts were observed as long as 3 mo after implantation. Immunohistological analyses revealed the presence of differentiated myotubes that stably expressed the skeletal myosin heavy chain isoform. Thymidine uptake studies indicated that virtually all of the grafted skeletal myocytes were withdrawn from the cell cycle by 14 d after grafting. Graft myocytes exhibited ultrastructural characteristics typical of differentiated myotubes. Graft formation and the associated myocardial remodeling did not induce overt cardiac arrhythmia. This study indicates that the myocardium can serve as a stable platform for skeletal myoblast grafts. The long-term survival, differentiated phenotype, and absence of sustained proliferative activity observed in myoblast grafts raise the possibility that similar grafting approaches may be used to replace diseased myocardium. Furthermore, the genetic tractability of myoblasts could provide a useful means for the local delivery of recombinant molecules to the heart.

Full text

PDF
1548

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbee R. W., Perry B. D., Ré R. N., Murgo J. P. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. Am J Physiol. 1992 Sep;263(3 Pt 2):R728–R733. doi: 10.1152/ajpregu.1992.263.3.R728. [DOI] [PubMed] [Google Scholar]
  2. Barr E., Leiden J. M. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science. 1991 Dec 6;254(5037):1507–1509. doi: 10.1126/science.1962212. [DOI] [PubMed] [Google Scholar]
  3. Behara A. M., Westcott A. J., Chang P. L. Intrathymic implants of genetically modified fibroblasts. FASEB J. 1992 Jul;6(10):2853–2858. doi: 10.1096/fasebj.6.10.1634049. [DOI] [PubMed] [Google Scholar]
  4. Behringer R. R., Peschon J. J., Messing A., Gartside C. L., Hauschka S. D., Palmiter R. D., Brinster R. L. Heart and bone tumors in transgenic mice. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2648–2652. doi: 10.1073/pnas.85.8.2648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beyer E. C., Paul D. L., Goodenough D. A. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol. 1987 Dec;105(6 Pt 1):2621–2629. doi: 10.1083/jcb.105.6.2621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Delcarpio J. B., Lanson N. A., Jr, Field L. J., Claycomb W. C. Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 cells). Circ Res. 1991 Dec;69(6):1591–1600. doi: 10.1161/01.res.69.6.1591. [DOI] [PubMed] [Google Scholar]
  8. Dhawan J., Pan L. C., Pavlath G. K., Travis M. A., Lanctot A. M., Blau H. M. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science. 1991 Dec 6;254(5037):1509–1512. doi: 10.1126/science.1962213. [DOI] [PubMed] [Google Scholar]
  9. Field L. J. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science. 1988 Feb 26;239(4843):1029–1033. doi: 10.1126/science.2964082. [DOI] [PubMed] [Google Scholar]
  10. Folkman J., Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. doi: 10.1126/science.2432664. [DOI] [PubMed] [Google Scholar]
  11. Gage F. H., Kawaja M. D., Fisher L. J. Genetically modified cells: applications for intracerebral grafting. Trends Neurosci. 1991 Aug;14(8):328–333. doi: 10.1016/0166-2236(91)90156-o. [DOI] [PubMed] [Google Scholar]
  12. Gussoni E., Pavlath G. K., Lanctot A. M., Sharma K. R., Miller R. G., Steinman L., Blau H. M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 1992 Apr 2;356(6368):435–438. doi: 10.1038/356435a0. [DOI] [PubMed] [Google Scholar]
  13. Hoffman S., Crossin K. L., Prediger E. A., Cunningham B. A., Edelman G. M. Expression and function of cell adhesion molecules during the early development of the heart. Ann N Y Acad Sci. 1990;588:73–86. doi: 10.1111/j.1749-6632.1990.tb13198.x. [DOI] [PubMed] [Google Scholar]
  14. Jackson T., Allard M. F., Sreenan C. M., Doss L. K., Bishop S. P., Swain J. L. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol. 1990 Jul;10(7):3709–3716. doi: 10.1128/mcb.10.7.3709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Janse M. J., Cinca J., Moréna H., Fiolet J. W., Kléber A. G., de Vries G. P., Becker A. E., Durrer D. The "border zone" in myocardial ischemia. An electrophysiological, metabolic, and histochemical correlation in the pig heart. Circ Res. 1979 Apr;44(4):576–588. doi: 10.1161/01.res.44.4.576. [DOI] [PubMed] [Google Scholar]
  16. Jiao S., Wolff J. A. Long-term survival of autologous muscle grafts in rat brain. Neurosci Lett. 1992 Mar 30;137(2):207–210. doi: 10.1016/0304-3940(92)90405-v. [DOI] [PubMed] [Google Scholar]
  17. Karpati G., Pouliot Y., Zubrzycka-Gaarn E., Carpenter S., Ray P. N., Worton R. G., Holland P. Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol. 1989 Jul;135(1):27–32. [PMC free article] [PubMed] [Google Scholar]
  18. Koh G. Y., Soonpaa M. H., Klug M. G., Field L. J. Long-term survival of AT-1 cardiomyocyte grafts in syngeneic myocardium. Am J Physiol. 1993 May;264(5 Pt 2):H1727–H1733. doi: 10.1152/ajpheart.1993.264.5.H1727. [DOI] [PubMed] [Google Scholar]
  19. Lanson N. A., Jr, Glembotski C. C., Steinhelper M. E., Field L. J., Claycomb W. C. Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes. Circulation. 1992 May;85(5):1835–1841. doi: 10.1161/01.cir.85.5.1835. [DOI] [PubMed] [Google Scholar]
  20. MAURO A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol. 1961 Feb;9:493–495. doi: 10.1083/jcb.9.2.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Markwald R. R., Mjaatvedt C. H., Krug E. L., Sinning A. R. Inductive interactions in heart development. Role of cardiac adherons in cushion tissue formation. Ann N Y Acad Sci. 1990;588:13–25. doi: 10.1111/j.1749-6632.1990.tb13193.x. [DOI] [PubMed] [Google Scholar]
  22. Morgan J. E., Hoffman E. P., Partridge T. A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol. 1990 Dec;111(6 Pt 1):2437–2449. doi: 10.1083/jcb.111.6.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Morgan J. E., Watt D. J., Sloper J. C., Partridge T. A. Partial correction of an inherited biochemical defect of skeletal muscle by grafts of normal muscle precursor cells. J Neurol Sci. 1988 Sep;86(2-3):137–147. doi: 10.1016/0022-510x(88)90093-7. [DOI] [PubMed] [Google Scholar]
  24. Nadal-Ginard B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 1978 Nov;15(3):855–864. doi: 10.1016/0092-8674(78)90270-2. [DOI] [PubMed] [Google Scholar]
  25. Ng W. A., Grupp I. L., Subramaniam A., Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991 Jun;68(6):1742–1750. doi: 10.1161/01.res.68.6.1742. [DOI] [PubMed] [Google Scholar]
  26. Partridge T. A., Morgan J. E., Coulton G. R., Hoffman E. P., Kunkel L. M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 1989 Jan 12;337(6203):176–179. doi: 10.1038/337176a0. [DOI] [PubMed] [Google Scholar]
  27. Plate K. H., Breier G., Weich H. A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature. 1992 Oct 29;359(6398):845–848. doi: 10.1038/359845a0. [DOI] [PubMed] [Google Scholar]
  28. Rockman H. A., Ross R. S., Harris A. N., Knowlton K. U., Steinhelper M. E., Field L. J., Ross J., Jr, Chien K. R. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8277–8281. doi: 10.1073/pnas.88.18.8277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rumyantsev P. P. Interrelations of the proliferation and differentiation processes during cardiact myogenesis and regeneration. Int Rev Cytol. 1977;51:186–273. [PubMed] [Google Scholar]
  30. Samuel J. L., Vandenburgh H. H. Mechanically induced orientation of adult rat cardiac myocytes in vitro. In Vitro Cell Dev Biol. 1990 Sep;26(9):905–914. doi: 10.1007/BF02624616. [DOI] [PubMed] [Google Scholar]
  31. Saule S., Mérigaud J. P., Al-Moustafa A. E., Ferré F., Rong P. M., Amouyel P., Quatannens B., Stéhelin D., Dieterlen-Lièvre F. Heart tumors specifically induced in young avian embryos by the v-myc oncogene. Proc Natl Acad Sci U S A. 1987 Nov;84(22):7982–7986. doi: 10.1073/pnas.84.22.7982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sen A., Dunnmon P., Henderson S. A., Gerard R. D., Chien K. R. Terminally differentiated neonatal rat myocardial cells proliferate and maintain specific differentiated functions following expression of SV40 large T antigen. J Biol Chem. 1988 Dec 15;263(35):19132–19136. [PubMed] [Google Scholar]
  33. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992 Oct 29;359(6398):843–845. doi: 10.1038/359843a0. [DOI] [PubMed] [Google Scholar]
  34. Spear J. F., Michelson E. L., Moore E. N. Cellular electrophysiologic characteristics of chronically infarcted myocardium in dogs susceptible to sustained ventricular tachyarrhythmias. J Am Coll Cardiol. 1983 Apr;1(4):1099–1110. doi: 10.1016/s0735-1097(83)80112-0. [DOI] [PubMed] [Google Scholar]
  35. Steinhelper M. E., Lanson N. A., Jr, Dresdner K. P., Delcarpio J. B., Wit A. L., Claycomb W. C., Field L. J. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am J Physiol. 1990 Dec;259(6 Pt 2):H1826–H1834. doi: 10.1152/ajpheart.1990.259.6.H1826. [DOI] [PubMed] [Google Scholar]
  36. Watt D. J., Morgan J. E., Partridge T. A. Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles. Muscle Nerve. 1984 Nov-Dec;7(9):741–750. doi: 10.1002/mus.880070908. [DOI] [PubMed] [Google Scholar]
  37. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977 Dec 22;270(5639):725–727. doi: 10.1038/270725a0. [DOI] [PubMed] [Google Scholar]
  38. Zipes D. P. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation. 1990 Oct;82(4):1095–1105. doi: 10.1161/01.cir.82.4.1095. [DOI] [PubMed] [Google Scholar]
  39. Zwiebel J. A., Freeman S. M., Newman K., Dichek D., Ryan U. S., Anderson W. F. Drug delivery by genetically engineered cell implants. Ann N Y Acad Sci. 1991;618:394–404. doi: 10.1111/j.1749-6632.1991.tb27259.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES